Evotec SE fiscal year 2020 results: Gaining speed on the "data-driven R&D Autobahn to Cures"




  • Very strong financial results: 12% increase in Group revenues beating guidance despite pandemic; unique innovation platforms and infrastructure support long-term growth in all modalities; solid balance sheet, strong foundation for next expansion steps Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-se-fiscal-year-2020-results-gaining-speed-on-the-data-driven-rd-autobahn-to-cures-6042

    Du magst vielleicht auch